Tech Company Financing Transactions
Enterin Funding Round
Enterin closed a $16.7 million funding round on 1/29/2019. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/29/2019
Transaction Type
Venture Equity
Amount
$16,699,970
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 6 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2005 Market St. 3125
Philadelphia, PA 19103
USA
Philadelphia, PA 19103
USA
Phone
Undisclosed
Website
Email Address
Overview
Enterin Inc. is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Zasloff
Chief Medical Officer
Denise Barbut
VP - R & D
William Kinney
Browse more venture capital transactions:
Prev: 1/28/2019: Obo venture capital transaction
Next: 1/29/2019: Knotch venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs